Compile Data Set for Download or QSAR
maximum 50k data
Found 43 Enz. Inhib. hit(s) with all data for entry = 50049289
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238227(CHEMBL4071377)
Affinity DataIC50:  2.90nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM8961(1,2,3,4-tetrahydro-9-acridinamine | 1,2,3,4-tetrah...)
Affinity DataIC50:  3.20nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238223(CHEMBL4102333)
Affinity DataIC50:  3.30nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238216(CHEMBL4095535)
Affinity DataIC50:  5.80nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238235(CHEMBL4081915)
Affinity DataIC50:  8.80nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238224(CHEMBL4094081)
Affinity DataIC50:  14nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238225(CHEMBL4060011)
Affinity DataIC50:  18nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238213(CHEMBL4066548)
Affinity DataIC50:  18nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238212(CHEMBL4077952)
Affinity DataIC50:  20nMAssay Description:Inhibition of AChE (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238236(CHEMBL4068149)
Affinity DataIC50:  26nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238220(CHEMBL4074062)
Affinity DataIC50:  28nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238222(CHEMBL4094591)
Affinity DataIC50:  30nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50117592(1-Benzyl-4-(5,6-dimethoxy-1-oxo-indan-2-ylmethyl)-...)
Affinity DataIC50:  37nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238228(CHEMBL4092048)
Affinity DataIC50:  41nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238240(CHEMBL4084371)
Affinity DataIC50:  60nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238219(CHEMBL4072999)
Affinity DataIC50:  91nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238239(CHEMBL4099873)
Affinity DataIC50:  262nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238220(CHEMBL4074062)
Affinity DataIC50:  262nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238229(CHEMBL4061527)
Affinity DataIC50:  428nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238231(CHEMBL4105085)
Affinity DataIC50:  653nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238215(CHEMBL4076930)
Affinity DataIC50:  678nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238234(CHEMBL4101303)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238233(CHEMBL4072865)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238232(CHEMBL4083445)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238230(CHEMBL4081776)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238217(CHEMBL4092123)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238238(CHEMBL4093567)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238237(CHEMBL4099794)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238218(CHEMBL4064413)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of AChE in human erythrocytes using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238240(CHEMBL4084371)
Affinity DataIC50:  1.62E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238216(CHEMBL4095535)
Affinity DataIC50:  1.79E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238213(CHEMBL4066548)
Affinity DataIC50:  1.92E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238222(CHEMBL4094591)
Affinity DataIC50:  2.99E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238236(CHEMBL4068149)
Affinity DataIC50:  3.06E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238223(CHEMBL4102333)
Affinity DataIC50:  3.34E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238239(CHEMBL4099873)
Affinity DataIC50:  3.63E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238219(CHEMBL4072999)
Affinity DataIC50:  3.82E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238218(CHEMBL4064413)
Affinity DataIC50:  4.77E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238235(CHEMBL4081915)
Affinity DataIC50:  5.93E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238224(CHEMBL4094081)
Affinity DataIC50:  5.99E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238228(CHEMBL4092048)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238215(CHEMBL4076930)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50238211(CHEMBL4083306)
Affinity DataIC50: >1.00E+6nMAssay Description:Inhibition of AChE (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed